Form 4: Omnicell Director Mary Garrett Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Mary Garrett, a director at Omnicell, reported the acquisition of 6,058 shares of common stock and the disposal of 10,091 shares on May 21, 2024.
Summary
- On May 21, 2024, Mary Garrett, a director of Omnicell, reported changes in her beneficial ownership of the company's stock.
- She acquired 6,058 shares of common stock as a grant of restricted shares under the company's equity incentive plan for her services as a board member.
- These shares were granted in accordance with the Issuer's Board of Directors Compensation Plan.
- The shares will vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders.
- She also disposed of 10,091 shares.
- Following these transactions, Garrett beneficially owns 10,091 shares of Omnicell stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and doesn't convey any positive or negative outlook.
Positives
- The grant of restricted stock to a director aligns their interests with those of the shareholders.
- The vesting of shares at the 2025 Annual Meeting of Stockholders incentivizes continued service and contribution to the company.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership by a company insider, which is common for publicly traded companies. It provides transparency to investors regarding the holdings of key individuals within the company.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the ownership of company stock by a director.
- The grant of restricted stock aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: acquisition of 6,058 shares and disposal of 10,091 shares. |
| 05/23/2024 | Date of signature by Attorney-in-Fact. |
| 2025 Annual Meeting of Stockholders | Date when the restricted shares will vest in full. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.